| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.09e-06 | 6 | 77 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.09e-06 | 6 | 77 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.68e-05 | 40 | 77 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 2.43e-05 | 15 | 77 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | denatured protein binding | 4.39e-05 | 3 | 77 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 1.46e-04 | 5 | 77 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 1.82e-04 | 73 | 77 | 4 | GO:0044183 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 4.19e-04 | 163 | 77 | 5 | GO:0031072 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 4.56e-04 | 39 | 77 | 3 | GO:0097718 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.11e-03 | 13 | 77 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 1.43e-03 | 126 | 77 | 4 | GO:0051082 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.43e-03 | 562 | 77 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.55e-03 | 441 | 77 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | E-box binding | 1.69e-03 | 61 | 77 | 3 | GO:0070888 | |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 9.92e-07 | 6 | 77 | 3 | GO:0070370 | |
| GeneOntologyBiologicalProcess | heat acclimation | 1.73e-06 | 7 | 77 | 3 | GO:0010286 | |
| GeneOntologyBiologicalProcess | DNA damage response | SETD2 EYA4 BRCA2 UBR5 RADX USP28 TP63 DYRK1A DCLRE1A MDM2 TRRAP HELQ CLOCK HSPA1A HSPA1B | 2.17e-06 | 959 | 77 | 15 | GO:0006974 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | SETD2 ATP7A GLI3 TP63 LAMA1 AHR ROBO1 ROBO2 SIX4 MDM2 PLXNA1 MAP3K1 LUZP1 | 3.76e-06 | 750 | 77 | 13 | GO:0048729 |
| GeneOntologyBiologicalProcess | protein refolding | 4.57e-06 | 30 | 77 | 4 | GO:0042026 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 8.61e-06 | 35 | 77 | 4 | GO:0051085 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | PTPN3 SETD2 CCNDBP1 BRCA2 USP28 TP63 CDK19 MDM2 MAP10 WNK1 TRRAP CLOCK HSPA1A HSPA1B HSPA8 MYO16 | 1.30e-05 | 1256 | 77 | 16 | GO:0051726 |
| GeneOntologyBiologicalProcess | negative regulation of negative chemotaxis | 1.38e-05 | 2 | 77 | 2 | GO:0050925 | |
| GeneOntologyBiologicalProcess | positive regulation of animal organ morphogenesis | 1.64e-05 | 41 | 77 | 4 | GO:0110110 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 1.64e-05 | 41 | 77 | 4 | GO:0051084 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | SETD2 ATP7A GLI3 TP63 LAMA1 AHR ROBO1 SIX4 PLXNA1 MAP3K1 LUZP1 | 1.80e-05 | 619 | 77 | 11 | GO:0002009 |
| GeneOntologyBiologicalProcess | heart development | SETD2 DSG2 ADAMTS6 GLI3 DUSP6 DYRK1A AHR ROBO1 ROBO2 MDM2 WNK1 LUZP1 | 2.25e-05 | 757 | 77 | 12 | GO:0007507 |
| GeneOntologyBiologicalProcess | epithelium development | SETD2 IL31RA ATP7A BRCA2 GLI3 TP63 LAMA1 AHR ROBO1 ROBO2 SIX4 CLOCK USH2A JMJD1C PLXNA1 MAP3K1 LUZP1 | 2.32e-05 | 1469 | 77 | 17 | GO:0060429 |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 2.60e-05 | 46 | 77 | 4 | GO:0006458 | |
| GeneOntologyBiologicalProcess | DNA repair | SETD2 EYA4 BRCA2 UBR5 RADX USP28 DCLRE1A TRRAP HELQ HSPA1A HSPA1B | 2.75e-05 | 648 | 77 | 11 | GO:0006281 |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | SETD2 ABCA1 DSG2 UBR5 TP63 DUSP6 AHR ATF1 MDM2 CLOCK HSPA1A HSPA1B HSPA8 EPHA5 | 2.94e-05 | 1048 | 77 | 14 | GO:0014070 |
| GeneOntologyBiologicalProcess | blood vessel development | SETD2 ATP7A ADAMTS6 GLI3 CD34 LAMA1 AHR ROBO1 ROBO2 MDM2 WNK1 LUZP1 EPHA5 | 3.65e-05 | 929 | 77 | 13 | GO:0001568 |
| GeneOntologyBiologicalProcess | gland development | 4.17e-05 | 558 | 77 | 10 | GO:0048732 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | FSIP2 STAM2 SETD2 BRCA2 UBR5 GLI3 NPAP1 DYRK1A AHR SIX4 MDM2 WNK1 MEAK7 HSPA8 | 4.56e-05 | 1091 | 77 | 14 | GO:0033365 |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 4.93e-05 | 54 | 77 | 4 | GO:2001239 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 5.04e-05 | 258 | 77 | 7 | GO:0001763 | |
| GeneOntologyBiologicalProcess | vasculature development | SETD2 ATP7A ADAMTS6 GLI3 CD34 LAMA1 AHR ROBO1 ROBO2 MDM2 WNK1 LUZP1 EPHA5 | 5.63e-05 | 969 | 77 | 13 | GO:0001944 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 6.11e-05 | 362 | 77 | 8 | GO:0034504 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | SETD2 BRCA2 USP28 TP63 MDM2 MAP10 WNK1 TRRAP CLOCK HSPA1A HSPA1B MYO16 | 6.55e-05 | 845 | 77 | 12 | GO:0010564 |
| GeneOntologyBiologicalProcess | circulatory system development | SETD2 ATP7A DSG2 ADAMTS6 GLI3 CD34 DUSP6 LAMA1 DYRK1A AHR ROBO1 ROBO2 MDM2 WNK1 LUZP1 EPHA5 | 6.98e-05 | 1442 | 77 | 16 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 7.44e-05 | 598 | 77 | 10 | GO:0080135 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SETD2 EYA4 RESF1 BRCA2 UBR5 TP63 DYRK1A AHR ZDBF2 TRRAP CLOCK JMJD1C PHC1 | 7.67e-05 | 999 | 77 | 13 | GO:0071824 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 8.20e-05 | 605 | 77 | 10 | GO:0071407 | |
| GeneOntologyBiologicalProcess | regulation of negative chemotaxis | 8.21e-05 | 4 | 77 | 2 | GO:0050923 | |
| GeneOntologyBiologicalProcess | nuclear transport | 8.26e-05 | 378 | 77 | 8 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 8.26e-05 | 378 | 77 | 8 | GO:0006913 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 8.72e-05 | 381 | 77 | 8 | GO:0048545 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | ABCA1 UBR5 TP63 CDK19 AHR CLOCK HSPA1A HSPA1B HSPA8 PHC1 EPHA5 | 1.00e-04 | 748 | 77 | 11 | GO:0071396 |
| GeneOntologyBiologicalProcess | chromatin organization | SETD2 EYA4 RESF1 BRCA2 UBR5 TP63 DYRK1A ZDBF2 TRRAP CLOCK JMJD1C PHC1 | 1.14e-04 | 896 | 77 | 12 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ABCA1 ATP7A RESF1 UBAP2L STXBP5 DYRK1A AHR ROBO1 ROBO2 SIX4 HSPA1A HSPA1B HSPA8 MAP3K1 | 1.15e-04 | 1189 | 77 | 14 | GO:0044087 |
| GeneOntologyBiologicalProcess | artery development | 1.41e-04 | 133 | 77 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.42e-04 | 212 | 77 | 6 | GO:0003205 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.46e-04 | 134 | 77 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | SETD2 EYA4 BRCA2 UBR5 RADX USP28 AHR DCLRE1A ATF1 TRRAP HELQ HSPA1A HSPA1B | 1.69e-04 | 1081 | 77 | 13 | GO:0006259 |
| GeneOntologyBiologicalProcess | tube development | SETD2 ATP7A GLI3 TP63 CD34 LAMA1 AHR ROBO1 ROBO2 TNRC6C SIX4 WNK1 JMJD1C LUZP1 EPHA5 | 1.83e-04 | 1402 | 77 | 15 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of nucleocytoplasmic transport | 1.91e-04 | 142 | 77 | 5 | GO:0046822 | |
| GeneOntologyBiologicalProcess | animal organ formation | 2.08e-04 | 78 | 77 | 4 | GO:0048645 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SETD2 EYA4 GLI3 TP63 CD34 LAMA1 AHR ROBO1 ROBO2 TSHZ1 SIX4 MDM2 USH2A PLXNA1 | 2.26e-04 | 1269 | 77 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | chaperone-mediated protein folding | 2.29e-04 | 80 | 77 | 4 | GO:0061077 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 2.40e-04 | 81 | 77 | 4 | GO:0034605 | |
| GeneOntologyBiologicalProcess | response to lipid | ABCA1 DSG2 UBR5 TP63 CDK19 AHR MDM2 CLOCK HSPA1A HSPA1B HSPA8 PHC1 EPHA5 | 2.52e-04 | 1126 | 77 | 13 | GO:0033993 |
| GeneOntologyBiologicalProcess | extrinsic apoptotic signaling pathway in absence of ligand | 2.52e-04 | 82 | 77 | 4 | GO:0097192 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 2.53e-04 | 236 | 77 | 6 | GO:0061138 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 2.64e-04 | 83 | 77 | 4 | GO:0010569 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 2.71e-04 | 239 | 77 | 6 | GO:0071383 | |
| GeneOntologyBiologicalProcess | signal transduction in absence of ligand | 2.76e-04 | 84 | 77 | 4 | GO:0038034 | |
| GeneOntologyBiologicalProcess | cranial skeletal system development | 2.76e-04 | 84 | 77 | 4 | GO:1904888 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.85e-04 | 7 | 77 | 2 | GO:0070434 | |
| GeneOntologyBiologicalProcess | negative regulation of mammary gland epithelial cell proliferation | 2.85e-04 | 7 | 77 | 2 | GO:0033600 | |
| GeneOntologyBiologicalProcess | axon midline choice point recognition | 2.85e-04 | 7 | 77 | 2 | GO:0016199 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 3.42e-04 | 161 | 77 | 5 | GO:0003231 | |
| GeneOntologyBiologicalProcess | intracellular transport | STAM2 SETD2 ABCA1 UBR5 GLI3 ITSN2 NPAP1 DYRK1A MDM2 WNK1 TFG HSPA1A HSPA1B HSPA8 DOP1A | 3.68e-04 | 1496 | 77 | 15 | GO:0046907 |
| GeneOntologyBiologicalProcess | ventricular septum development | 3.75e-04 | 91 | 77 | 4 | GO:0003281 | |
| GeneOntologyBiologicalProcess | heart induction | 3.80e-04 | 8 | 77 | 2 | GO:0003129 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 3.80e-04 | 8 | 77 | 2 | GO:0090063 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 3.80e-04 | 8 | 77 | 2 | GO:0070426 | |
| GeneOntologyBiologicalProcess | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 3.80e-04 | 8 | 77 | 2 | GO:0071947 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway by p53 class mediator | 4.08e-04 | 93 | 77 | 4 | GO:0072332 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 4.21e-04 | 741 | 77 | 10 | GO:0006338 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | ATP7A STXBP5 GLI3 ITSN2 LAMA1 AHR ROBO1 ROBO2 JMJD1C PLXNA1 MYO16 MAP3K1 EPHA5 | 4.42e-04 | 1194 | 77 | 13 | GO:0000902 |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 4.47e-04 | 40 | 77 | 3 | GO:2001240 | |
| GeneOntologyBiologicalProcess | negative regulation of signal transduction in absence of ligand | 4.47e-04 | 40 | 77 | 3 | GO:1901099 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | 4.73e-04 | 489 | 77 | 8 | GO:0043254 | |
| GeneOntologyBiologicalProcess | forebrain development | 4.73e-04 | 489 | 77 | 8 | GO:0030900 | |
| GeneOntologyBiologicalProcess | kidney development | 4.77e-04 | 372 | 77 | 7 | GO:0001822 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ABCA1 ATP7A RESF1 UBAP2L AHR ROBO1 ROBO2 ATF1 WNK1 HSPA1A HSPA1B HSPA8 PLXNA1 MAP3K1 | 4.78e-04 | 1366 | 77 | 14 | GO:0051130 |
| GeneOntologyBiologicalProcess | specification of animal organ identity | 4.81e-04 | 41 | 77 | 3 | GO:0010092 | |
| GeneOntologyBiologicalProcess | regulation of heart morphogenesis | 4.87e-04 | 9 | 77 | 2 | GO:2000826 | |
| GeneOntologyBiologicalProcess | axon choice point recognition | 4.87e-04 | 9 | 77 | 2 | GO:0016198 | |
| GeneOntologyBiologicalProcess | regulation of cytokinesis | 5.17e-04 | 99 | 77 | 4 | GO:0032465 | |
| GeneOntologyBiologicalProcess | cellular response to chemical stress | 5.17e-04 | 377 | 77 | 7 | GO:0062197 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 5.41e-04 | 178 | 77 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | endocardial cushion morphogenesis | 5.93e-04 | 44 | 77 | 3 | GO:0003203 | |
| GeneOntologyBiologicalProcess | renal system development | 5.94e-04 | 386 | 77 | 7 | GO:0072001 | |
| GeneOntologyBiologicalProcess | response to cobalt ion | 6.07e-04 | 10 | 77 | 2 | GO:0032025 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process | 6.20e-04 | 640 | 77 | 9 | GO:0006511 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 6.93e-04 | 188 | 77 | 5 | GO:0000724 | |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | 7.00e-04 | 651 | 77 | 9 | GO:0019941 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 7.01e-04 | 286 | 77 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | 7.39e-04 | 656 | 77 | 9 | GO:0043632 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 7.40e-04 | 11 | 77 | 2 | GO:0021891 | |
| GeneOntologyBiologicalProcess | regulation of mRNA export from nucleus | 7.40e-04 | 11 | 77 | 2 | GO:0010793 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 7.40e-04 | 11 | 77 | 2 | GO:0070432 | |
| GeneOntologyBiologicalProcess | signal transduction by p53 class mediator | 7.44e-04 | 191 | 77 | 5 | GO:0072331 | |
| GeneOntologyBiologicalProcess | regulation of animal organ morphogenesis | 7.68e-04 | 110 | 77 | 4 | GO:2000027 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ATP7A STXBP5 GLI3 ITSN2 LAMA1 ROBO1 ROBO2 PLXNA1 MYO16 EPHA5 | 7.77e-04 | 802 | 77 | 10 | GO:0048812 |
| GeneOntologyBiologicalProcess | recombinational repair | 7.98e-04 | 194 | 77 | 5 | GO:0000725 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 8.15e-04 | 49 | 77 | 3 | GO:0042771 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 8.17e-04 | 195 | 77 | 5 | GO:0006606 | |
| GeneOntologyBiologicalProcess | cellular response to oxidative stress | 8.24e-04 | 295 | 77 | 6 | GO:0034599 | |
| GeneOntologyBiologicalProcess | cell recognition | 8.75e-04 | 198 | 77 | 5 | GO:0008037 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 8.86e-04 | 12 | 77 | 2 | GO:0090084 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ATP7A STXBP5 GLI3 ITSN2 LAMA1 ROBO1 ROBO2 PLXNA1 MYO16 EPHA5 | 9.11e-04 | 819 | 77 | 10 | GO:0120039 |
| GeneOntologyBiologicalProcess | signal transduction in response to DNA damage | 9.15e-04 | 200 | 77 | 5 | GO:0042770 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 9.22e-04 | 416 | 77 | 7 | GO:0030522 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BRCA2 UBAP2L MAX CDK19 NPAP1 AHR RBM5 ATF1 TRRAP CLOCK HSPA1A HSPA1B JMJD1C HSPA6 HSPA8 PHC1 | 5.60e-05 | 1377 | 80 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear body | CCNDBP1 RADX USP28 GLI3 MAX DYRK1A EWSR1 MDM2 HSPA1A HSPA1B PHC1 PAPOLG | 1.58e-04 | 903 | 80 | 12 | GO:0016604 |
| GeneOntologyCellularComponent | transcription repressor complex | 3.48e-04 | 87 | 80 | 4 | GO:0017053 | |
| GeneOntologyCellularComponent | COP9 signalosome | 4.13e-04 | 38 | 80 | 3 | GO:0008180 | |
| GeneOntologyCellularComponent | transcription regulator complex | 4.49e-04 | 596 | 80 | 9 | GO:0005667 | |
| GeneOntologyCellularComponent | apical plasma membrane | 5.47e-04 | 487 | 80 | 8 | GO:0016324 | |
| HumanPheno | Renal hypoplasia/aplasia | BRCA2 GLI3 TP63 MAX DUSP6 DYRK1A ROBO1 ROBO2 MDM2 TRRAP JMJD1C PLXNA1 PHC1 | 1.29e-06 | 359 | 39 | 13 | HP:0008678 |
| HumanPheno | Cutaneous syndactyly of toes | 3.33e-05 | 50 | 39 | 5 | HP:0010621 | |
| MousePheno | abnormal heart right ventricle wall morphology | 4.40e-06 | 52 | 66 | 5 | MP:0031534 | |
| MousePheno | abnormal mammary gland morphology | 4.47e-06 | 201 | 66 | 8 | MP:0000627 | |
| MousePheno | abnormal apocrine gland morphology | 4.47e-06 | 201 | 66 | 8 | MP:0013554 | |
| MousePheno | abnormal olfactory tract morphology | 5.54e-06 | 8 | 66 | 3 | MP:0005237 | |
| MousePheno | decreased spleen weight | 1.50e-05 | 113 | 66 | 6 | MP:0004953 | |
| MousePheno | abnormal spinal cord lateral column morphology | 2.20e-05 | 2 | 66 | 2 | MP:0009678 | |
| MousePheno | small spleen | 2.33e-05 | 416 | 66 | 10 | MP:0000692 | |
| MousePheno | abnormal epidermis stratum basale morphology | 2.66e-05 | 37 | 66 | 4 | MP:0001231 | |
| MousePheno | spleen hypoplasia | 3.04e-05 | 128 | 66 | 6 | MP:0000694 | |
| MousePheno | abnormal olfactory cortex morphology | 4.39e-05 | 15 | 66 | 3 | MP:0005267 | |
| MousePheno | heart right ventricle hypertrophy | 4.43e-05 | 42 | 66 | 4 | MP:0000276 | |
| MousePheno | increased classified tumor incidence | 7.08e-05 | 381 | 66 | 9 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 7.52e-05 | 384 | 66 | 9 | MP:0020188 | |
| MousePheno | increased organ/body region tumor incidence | 9.33e-05 | 395 | 66 | 9 | MP:0010274 | |
| MousePheno | abnormal organ/body region tumor incidence | 1.05e-04 | 401 | 66 | 9 | MP:0013152 | |
| MousePheno | increased malignant tumor incidence | 1.23e-04 | 237 | 66 | 7 | MP:0002018 | |
| MousePheno | abnormal palate morphology | 1.28e-04 | 321 | 66 | 8 | MP:0003755 | |
| MousePheno | increased heart right ventricle size | 1.29e-04 | 55 | 66 | 4 | MP:0010563 | |
| MousePheno | abnormal adenoma incidence | 1.68e-04 | 110 | 66 | 5 | MP:0020189 | |
| MousePheno | increased adenoma incidence | 1.68e-04 | 110 | 66 | 5 | MP:0010383 | |
| MousePheno | abnormal thymus weight | 1.81e-04 | 60 | 66 | 4 | MP:0004954 | |
| MousePheno | abnormal appendicular skeleton morphology | SETD2 ATP7A BRCA2 ADAMTS6 UBAP2L GLI3 TP63 DUSP6 TSHZ1 EWSR1 TOX2 PLXNA1 PHC1 | 2.41e-04 | 896 | 66 | 13 | MP:0009250 |
| MousePheno | abnormal mouth morphology | EYA4 ADAMTS6 GLI3 TP63 OTUD7A ROBO1 TSHZ1 MDM2 CLOCK LUZP1 PHC1 | 2.73e-04 | 670 | 66 | 11 | MP:0000452 |
| MousePheno | abnormal spleen weight | 2.85e-04 | 361 | 66 | 8 | MP:0004951 | |
| MousePheno | increased carcinoma incidence | 3.27e-04 | 197 | 66 | 6 | MP:0002038 | |
| MousePheno | rectal prolapse | 3.36e-04 | 29 | 66 | 3 | MP:0000493 | |
| MousePheno | abnormal skin adnexa morphology | ATP7A CEACAM21 BRCA2 DSG2 GLI3 TP63 CD34 ITSN2 AHR ROBO1 EWSR1 TNRC6C MDM2 HELQ DOP1A PAPOLG | 3.93e-04 | 1341 | 66 | 16 | MP:0010678 |
| MousePheno | cleft palate | 4.12e-04 | 289 | 66 | 7 | MP:0000111 | |
| MousePheno | oral cleft | 4.29e-04 | 291 | 66 | 7 | MP:0021164 | |
| MousePheno | increased integument system tumor incidence | 4.50e-04 | 76 | 66 | 4 | MP:0010293 | |
| MousePheno | abnormal throat morphology | 4.54e-04 | 7 | 66 | 2 | MP:0010370 | |
| MousePheno | abnormal epiglottis morphology | 4.54e-04 | 7 | 66 | 2 | MP:0010371 | |
| MousePheno | perinatal lethality, complete penetrance | EYA4 ATP7A EBF3 GLI3 TP63 ROBO1 ROBO2 TSHZ1 TNRC6C LUZP1 PHC1 | 4.58e-04 | 712 | 66 | 11 | MP:0011089 |
| MousePheno | abnormal heart right ventricle size | 4.97e-04 | 78 | 66 | 4 | MP:0010577 | |
| MousePheno | abnormal palatal shelf fusion at midline | 5.48e-04 | 80 | 66 | 4 | MP:0009887 | |
| MousePheno | absent epidermis stratum corneum | 6.04e-04 | 8 | 66 | 2 | MP:0001241 | |
| MousePheno | decreased cell proliferation | JAK3 CCNDBP1 BRCA2 DSG2 UBR5 TP63 CD34 MAX CDK19 DCLRE1A MDM2 | 6.26e-04 | 739 | 66 | 11 | MP:0000352 |
| MousePheno | decreased thymus weight | 6.42e-04 | 36 | 66 | 3 | MP:0004956 | |
| MousePheno | abnormal olfactory lobe morphology | 6.82e-04 | 149 | 66 | 5 | MP:0009944 | |
| MousePheno | increased mammary gland tumor incidence | 7.54e-04 | 38 | 66 | 3 | MP:0010299 | |
| MousePheno | absent radius | 7.74e-04 | 9 | 66 | 2 | MP:0000553 | |
| MousePheno | heart inflammation | 8.14e-04 | 39 | 66 | 3 | MP:0001853 | |
| MousePheno | increased tumor incidence | 8.16e-04 | 530 | 66 | 9 | MP:0002020 | |
| MousePheno | abnormal craniofacial development | 8.38e-04 | 425 | 66 | 8 | MP:0003935 | |
| MousePheno | abnormal heart right ventricle morphology | 8.39e-04 | 156 | 66 | 5 | MP:0003920 | |
| MousePheno | abnormal secondary palate morphology | 9.13e-04 | 159 | 66 | 5 | MP:0013550 | |
| MousePheno | abnormal extraembryonic tissue morphology | JAK3 SETD2 ABCA1 ATP7A BRCA2 UBR5 ADAMTS6 TP63 LAMA1 ROBO1 WNK1 TRRAP | 9.92e-04 | 908 | 66 | 12 | MP:0002086 |
| Domain | LRRC37AB_C | 2.90e-07 | 4 | 79 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.90e-07 | 4 | 79 | 3 | IPR032754 | |
| Domain | LRRC37AB_C | 2.90e-07 | 4 | 79 | 3 | IPR029423 | |
| Domain | LRRC37 | 2.90e-07 | 4 | 79 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.90e-07 | 4 | 79 | 3 | IPR015753 | |
| Domain | HSP70 | 5.19e-07 | 16 | 79 | 4 | PF00012 | |
| Domain | HSP70_2 | 6.77e-07 | 17 | 79 | 4 | PS00329 | |
| Domain | HSP70_3 | 6.77e-07 | 17 | 79 | 4 | PS01036 | |
| Domain | HSP70_1 | 6.77e-07 | 17 | 79 | 4 | PS00297 | |
| Domain | Hsp_70_fam | 8.67e-07 | 18 | 79 | 4 | IPR013126 | |
| Domain | - | 1.56e-05 | 12 | 79 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 1.56e-05 | 12 | 79 | 3 | IPR029047 | |
| Domain | - | 2.02e-05 | 13 | 79 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 2.02e-05 | 13 | 79 | 3 | IPR018181 | |
| Domain | HSP70_C | 2.02e-05 | 13 | 79 | 3 | IPR029048 | |
| Domain | zf-RanBP | 1.06e-04 | 22 | 79 | 3 | PF00641 | |
| Domain | ZF_RANBP2_2 | 1.21e-04 | 23 | 79 | 3 | PS50199 | |
| Domain | ZF_RANBP2_1 | 1.38e-04 | 24 | 79 | 3 | PS01358 | |
| Domain | UBA-like | 1.55e-04 | 64 | 79 | 4 | IPR009060 | |
| Domain | Znf_RanBP2 | 1.57e-04 | 25 | 79 | 3 | IPR001876 | |
| Domain | fn3 | 6.20e-04 | 162 | 79 | 5 | PF00041 | |
| Domain | - | 7.78e-04 | 10 | 79 | 2 | 4.10.1060.10 | |
| Domain | FN3 | 1.13e-03 | 185 | 79 | 5 | SM00060 | |
| Domain | HLH | 1.48e-03 | 116 | 79 | 4 | SM00353 | |
| Domain | FN3 | 1.55e-03 | 199 | 79 | 5 | PS50853 | |
| Domain | FN3_dom | 1.93e-03 | 209 | 79 | 5 | IPR003961 | |
| Domain | Laminin_N | 2.04e-03 | 16 | 79 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 2.04e-03 | 16 | 79 | 2 | PS51117 | |
| Domain | Laminin_N | 2.04e-03 | 16 | 79 | 2 | PF00055 | |
| Domain | LamNT | 2.04e-03 | 16 | 79 | 2 | SM00136 | |
| Domain | UIM | 3.52e-03 | 21 | 79 | 2 | SM00726 | |
| Domain | PAS_fold_3 | 4.22e-03 | 23 | 79 | 2 | IPR013655 | |
| Domain | ZnF_RBZ | 4.22e-03 | 23 | 79 | 2 | SM00547 | |
| Domain | PAS_3 | 4.22e-03 | 23 | 79 | 2 | PF08447 | |
| Domain | UIM | 4.59e-03 | 24 | 79 | 2 | PS50330 | |
| Domain | PAS | 4.98e-03 | 25 | 79 | 2 | PF00989 | |
| Domain | PAS_fold | 4.98e-03 | 25 | 79 | 2 | IPR013767 | |
| Domain | UIM_dom | 4.98e-03 | 25 | 79 | 2 | IPR003903 | |
| Domain | PAC | 5.38e-03 | 26 | 79 | 2 | IPR001610 | |
| Domain | PAC | 5.38e-03 | 26 | 79 | 2 | SM00086 | |
| Domain | PAC | 5.38e-03 | 26 | 79 | 2 | PS50113 | |
| Domain | IPT | 5.79e-03 | 27 | 79 | 2 | SM00429 | |
| Domain | SAM | 6.18e-03 | 88 | 79 | 3 | SM00454 | |
| Domain | - | 6.88e-03 | 663 | 79 | 8 | 2.60.40.10 | |
| Domain | EGF_LAM_2 | 7.12e-03 | 30 | 79 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 7.12e-03 | 30 | 79 | 2 | PS01248 | |
| Domain | UBA | 7.12e-03 | 30 | 79 | 2 | SM00165 | |
| Domain | TIG | 7.59e-03 | 31 | 79 | 2 | PF01833 | |
| Domain | SAM_DOMAIN | 7.63e-03 | 95 | 79 | 3 | PS50105 | |
| Domain | Kinase-like_dom | 7.99e-03 | 542 | 79 | 7 | IPR011009 | |
| Domain | IPT | 8.07e-03 | 32 | 79 | 2 | IPR002909 | |
| Domain | PAS | 8.07e-03 | 32 | 79 | 2 | SM00091 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 5.26e-06 | 28 | 59 | 4 | M27254 | |
| Pathway | WP_MAPK_SIGNALING | 7.89e-06 | 246 | 59 | 8 | M39597 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 1.43e-05 | 267 | 59 | 8 | M10792 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.84e-05 | 38 | 59 | 4 | M27255 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.93e-05 | 13 | 59 | 3 | MM14952 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 5.34e-05 | 160 | 59 | 6 | MM15990 | |
| Pathway | WP_APOPTOSIS_MODULATION_BY_HSP70 | 5.43e-05 | 18 | 59 | 3 | MM15964 | |
| Pathway | KEGG_ENDOCYTOSIS | 1.06e-04 | 181 | 59 | 6 | M1519 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.16e-04 | 23 | 59 | 3 | MM14953 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 2.18e-04 | 71 | 59 | 4 | M39690 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_ACTIVATION | 2.56e-04 | 6 | 59 | 2 | M47444 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 2.56e-04 | 136 | 59 | 5 | M42547 | |
| Pathway | REACTOME_HSF1_ACTIVATION | 2.88e-04 | 31 | 59 | 3 | M27252 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.79e-04 | 82 | 59 | 4 | M27250 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 4.97e-04 | 88 | 59 | 4 | M16004 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 7.58e-04 | 10 | 59 | 2 | M27348 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 8.35e-04 | 101 | 59 | 4 | M27253 | |
| Pubmed | SETD2 BRCA2 UBR5 USP28 CDK19 RBM5 DCLRE1A EWSR1 HSPA1A JMJD1C LUZP1 PHC1 | 6.48e-10 | 453 | 81 | 12 | 29656893 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | STAM2 SETD2 RESF1 BRCA2 UBR5 RADX USP28 MAX ZDBF2 MDM2 WNK1 LUZP1 PAPOLG | 1.06e-09 | 588 | 81 | 13 | 38580884 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | PRDM10 EYA4 UBR5 EBF3 USP28 MAX DYRK1A TSHZ1 ATF1 QSER1 SIX4 MDM2 TRRAP JMJD1C HSPA8 | 1.19e-09 | 857 | 81 | 15 | 25609649 |
| Pubmed | 3.41e-09 | 9 | 81 | 4 | 21763498 | ||
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 5.67e-09 | 10 | 81 | 4 | 11932435 | |
| Pubmed | 5.67e-09 | 10 | 81 | 4 | 12832005 | ||
| Pubmed | 5.67e-09 | 10 | 81 | 4 | 7906708 | ||
| Pubmed | 5.67e-09 | 10 | 81 | 4 | 23921388 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 24061851 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 23352621 | ||
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 1.22e-08 | 3 | 81 | 3 | 15129916 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 28025138 | ||
| Pubmed | HIV-1 viral protein R (Vpr) and its interactions with host cell. | 1.33e-08 | 12 | 81 | 4 | 19275587 | |
| Pubmed | Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase. | 1.86e-08 | 35 | 81 | 5 | 19287380 | |
| Pubmed | 3.65e-08 | 15 | 81 | 4 | 10964507 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZBTB44 SETD2 EYA4 MAX RBM5 DCLRE1A EWSR1 ATF1 QSER1 SIX4 TRRAP CLOCK HSPA1B JMJD1C HSPA6 HSPA8 | 4.23e-08 | 1294 | 81 | 16 | 30804502 |
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 22419166 | ||
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 4.86e-08 | 4 | 81 | 3 | 18299791 | |
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 4.86e-08 | 4 | 81 | 3 | 22956628 | |
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 18379898 | ||
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 4.86e-08 | 16 | 81 | 4 | 21738476 | |
| Pubmed | RESF1 BRCA2 UBR5 ZDBF2 HSPA1A HSPA1B JMJD1C HSPA6 LUZP1 PHC1 | 4.96e-08 | 418 | 81 | 10 | 34709266 | |
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 1.21e-07 | 5 | 81 | 3 | 11584023 | |
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 1.21e-07 | 5 | 81 | 3 | 16906134 | |
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 24718257 | ||
| Pubmed | Molecular mechanism of mutant p53 stabilization: the role of HSP70 and MDM2. | 1.21e-07 | 5 | 81 | 3 | 23251530 | |
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 17182002 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.56e-07 | 256 | 81 | 8 | 33397691 | |
| Pubmed | Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS. | 2.34e-07 | 23 | 81 | 4 | 24360543 | |
| Pubmed | The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. | 2.34e-07 | 23 | 81 | 4 | 21231916 | |
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 2.42e-07 | 6 | 81 | 3 | 7988674 | |
| Pubmed | Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. | 2.42e-07 | 6 | 81 | 3 | 15963462 | |
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 9305631 | ||
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 2.42e-07 | 6 | 81 | 3 | 25281747 | |
| Pubmed | Heat shock factor 2 is activated during mouse heart development. | 2.42e-07 | 6 | 81 | 3 | 11032181 | |
| Pubmed | 2.80e-07 | 24 | 81 | 4 | 10617616 | ||
| Pubmed | 3.96e-07 | 399 | 81 | 9 | 35987950 | ||
| Pubmed | Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. | 4.23e-07 | 7 | 81 | 3 | 10205060 | |
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 4.60e-07 | 27 | 81 | 4 | 23395962 | |
| Pubmed | 6.19e-07 | 421 | 81 | 9 | 34650049 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 6.51e-07 | 211 | 81 | 7 | 24097068 | |
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 6.76e-07 | 8 | 81 | 3 | 9122205 | |
| Pubmed | PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. | 6.76e-07 | 8 | 81 | 3 | 25485759 | |
| Pubmed | Identification of Redox and Glucose-Dependent Txnip Protein Interactions. | 9.34e-07 | 32 | 81 | 4 | 27437069 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 9.62e-07 | 444 | 81 | 9 | 34795231 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 9.94e-07 | 327 | 81 | 8 | 15592455 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.05e-06 | 583 | 81 | 10 | 29844126 | |
| Pubmed | SETD2 RADX RBM5 ROBO1 DCLRE1A ZDBF2 QSER1 WNK1 TFG JMJD1C PAPOLG | 1.07e-06 | 733 | 81 | 11 | 34672954 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.34e-06 | 235 | 81 | 7 | 30258100 | |
| Pubmed | 1.44e-06 | 10 | 81 | 3 | 23064749 | ||
| Pubmed | 1.56e-06 | 152 | 81 | 6 | 38360978 | ||
| Pubmed | ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. | 1.98e-06 | 11 | 81 | 3 | 27708256 | |
| Pubmed | 1.98e-06 | 11 | 81 | 3 | 24318877 | ||
| Pubmed | 2.59e-06 | 41 | 81 | 4 | 32723828 | ||
| Pubmed | 2.64e-06 | 12 | 81 | 3 | 12150907 | ||
| Pubmed | 3.42e-06 | 13 | 81 | 3 | 30792309 | ||
| Pubmed | UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. | 3.42e-06 | 13 | 81 | 3 | 27477512 | |
| Pubmed | BMI1-UBR5 axis regulates transcriptional repression at damaged chromatin. | 3.42e-06 | 13 | 81 | 3 | 27647897 | |
| Pubmed | 3.69e-06 | 274 | 81 | 7 | 34244482 | ||
| Pubmed | 4.02e-06 | 101 | 81 | 5 | 10997877 | ||
| Pubmed | EYA4 RESF1 UBAP2L RADX GLI3 MAX EWSR1 ATF1 QSER1 TNRC6C SIX4 MDM2 TRRAP JMJD1C | 5.08e-06 | 1429 | 81 | 14 | 35140242 | |
| Pubmed | 5.18e-06 | 187 | 81 | 6 | 26460568 | ||
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 5.36e-06 | 2 | 81 | 2 | 12411538 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 2868009 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 5.36e-06 | 2 | 81 | 2 | 24328534 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 3786141 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28559020 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 7813466 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 5.36e-06 | 2 | 81 | 2 | 26923070 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 27020764 | ||
| Pubmed | Robo signaling regulates the production of cranial neural crest cells. | 5.36e-06 | 2 | 81 | 2 | 28987541 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 16482515 | ||
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 5.36e-06 | 2 | 81 | 2 | 11864979 | |
| Pubmed | ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis. | 5.36e-06 | 2 | 81 | 2 | 23246965 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 36292946 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15719414 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26976620 | ||
| Pubmed | Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells. | 5.36e-06 | 2 | 81 | 2 | 32128997 | |
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 5.36e-06 | 2 | 81 | 2 | 21187371 | |
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 5.36e-06 | 2 | 81 | 2 | 20430459 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 5.36e-06 | 2 | 81 | 2 | 20876613 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20223214 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 5.36e-06 | 2 | 81 | 2 | 23704948 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31597096 | ||
| Pubmed | Structure and expression of the human gene encoding major heat shock protein HSP70. | 5.36e-06 | 2 | 81 | 2 | 2858050 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 5.36e-06 | 2 | 81 | 2 | 12207910 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28837204 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 29572464 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15988927 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 29090408 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 35442829 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26448330 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11992546 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12714332 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19299581 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11713291 | ||
| Pubmed | Heat shock protein 72 (Hsp72) improves long term recovery after focal cerebral ischemia in mice. | 5.36e-06 | 2 | 81 | 2 | 21108992 | |
| Interaction | EYA4 interactions | 5.70e-07 | 243 | 81 | 9 | int:EYA4 | |
| Interaction | RFPL2 interactions | 1.68e-06 | 22 | 81 | 4 | int:RFPL2 | |
| Interaction | STAM interactions | 2.75e-06 | 153 | 81 | 7 | int:STAM | |
| Interaction | CCDC117 interactions | 3.38e-06 | 26 | 81 | 4 | int:CCDC117 | |
| Interaction | DNAJB2 interactions | 3.46e-06 | 102 | 81 | 6 | int:DNAJB2 | |
| Interaction | POU5F1 interactions | RESF1 UBR5 UBAP2L MAX LAMA1 MUC16 EWSR1 TRRAP TOX2 JMJD1C HSPA8 PHC1 | 3.58e-06 | 584 | 81 | 12 | int:POU5F1 |
| Interaction | RPS6KA1 interactions | 3.75e-06 | 228 | 81 | 8 | int:RPS6KA1 | |
| Interaction | PDLIM4 interactions | 3.96e-06 | 27 | 81 | 4 | int:PDLIM4 | |
| Interaction | KDM1A interactions | RESF1 BRCA2 UBR5 USP28 MAX ITSN2 ZDBF2 TRRAP CLOCK HSPA1A HSPA1B JMJD1C HSPA6 LUZP1 PHC1 | 4.43e-06 | 941 | 81 | 15 | int:KDM1A |
| Interaction | RCOR1 interactions | RESF1 BRCA2 UBR5 MAX ZDBF2 CLOCK HSPA1A HSPA1B JMJD1C HSPA6 LUZP1 | 4.43e-06 | 494 | 81 | 11 | int:RCOR1 |
| Interaction | CCNI2 interactions | 5.16e-06 | 9 | 81 | 3 | int:CCNI2 | |
| Interaction | WWTR1 interactions | 7.27e-06 | 422 | 81 | 10 | int:WWTR1 | |
| Interaction | FAM50A interactions | 7.29e-06 | 116 | 81 | 6 | int:FAM50A | |
| Interaction | PHF21A interactions | 9.59e-06 | 343 | 81 | 9 | int:PHF21A | |
| Interaction | CLTA interactions | 1.15e-05 | 351 | 81 | 9 | int:CLTA | |
| Interaction | FAM83F interactions | 1.29e-05 | 36 | 81 | 4 | int:FAM83F | |
| Interaction | CIC interactions | ZBTB44 SETD2 EYA4 EBF3 DYRK1A EWSR1 ATF1 ZDBF2 SIX4 HSPA1A HSPA1B HSPA8 | 1.50e-05 | 673 | 81 | 12 | int:CIC |
| Interaction | DNAJA4 interactions | 1.65e-05 | 79 | 81 | 5 | int:DNAJA4 | |
| Interaction | LRRC28 interactions | 1.74e-05 | 13 | 81 | 3 | int:LRRC28 | |
| Interaction | CFAP52 interactions | 1.74e-05 | 13 | 81 | 3 | int:CFAP52 | |
| Interaction | JUN interactions | 1.85e-05 | 470 | 81 | 10 | int:JUN | |
| Interaction | CEACAM5 interactions | 2.21e-05 | 14 | 81 | 3 | int:CEACAM5 | |
| Interaction | FHL2 interactions | 2.99e-05 | 396 | 81 | 9 | int:FHL2 | |
| Interaction | BRCA1 interactions | BRCA2 UBR5 UBAP2L USP28 TP63 DYRK1A AHR DCLRE1A EWSR1 ATF1 TNRC6C TFG USH2A HSPA8 MAP3K1 LUZP1 | 3.15e-05 | 1249 | 81 | 16 | int:BRCA1 |
| Interaction | RAD23A interactions | 3.30e-05 | 224 | 81 | 7 | int:RAD23A | |
| Interaction | TSSK6 interactions | 3.79e-05 | 47 | 81 | 4 | int:TSSK6 | |
| Interaction | SPDL1 interactions | 3.90e-05 | 315 | 81 | 8 | int:SPDL1 | |
| Interaction | C3orf38 interactions | 4.08e-05 | 17 | 81 | 3 | int:C3orf38 | |
| Interaction | KCNA3 interactions | STAM2 ATP7A DSG2 UBAP2L LAMA1 ROBO1 HELQ HSPA1B JMJD1C HSPA8 LUZP1 DOP1A PAPOLG | 4.14e-05 | 871 | 81 | 13 | int:KCNA3 |
| Interaction | UBE2D2 interactions | 4.17e-05 | 318 | 81 | 8 | int:UBE2D2 | |
| Interaction | MDC1 interactions | 4.22e-05 | 414 | 81 | 9 | int:MDC1 | |
| Interaction | SMG7 interactions | 4.26e-05 | 319 | 81 | 8 | int:SMG7 | |
| Interaction | TGM2 interactions | 4.48e-05 | 235 | 81 | 7 | int:TGM2 | |
| Interaction | HIPK2 interactions | 4.69e-05 | 98 | 81 | 5 | int:HIPK2 | |
| Interaction | CPSF6 interactions | 4.80e-05 | 526 | 81 | 10 | int:CPSF6 | |
| Interaction | GPNMB interactions | 4.89e-05 | 18 | 81 | 3 | int:GPNMB | |
| Interaction | ILRUN interactions | 4.89e-05 | 18 | 81 | 3 | int:ILRUN | |
| Interaction | DNAJC7 interactions | 5.17e-05 | 425 | 81 | 9 | int:DNAJC7 | |
| Interaction | MCRIP2 interactions | 5.24e-05 | 51 | 81 | 4 | int:MCRIP2 | |
| Interaction | TP53BP1 interactions | BRCA2 UBR5 USP28 CDK19 RBM5 DCLRE1A EWSR1 HSPA1A JMJD1C HSPA8 | 5.37e-05 | 533 | 81 | 10 | int:TP53BP1 |
| Interaction | PHLPP1 interactions | 5.76e-05 | 333 | 81 | 8 | int:PHLPP1 | |
| Interaction | CEP85 interactions | 6.14e-05 | 169 | 81 | 6 | int:CEP85 | |
| Interaction | PMS1 interactions | 6.53e-05 | 105 | 81 | 5 | int:PMS1 | |
| Interaction | SENP2 interactions | 6.55e-05 | 171 | 81 | 6 | int:SENP2 | |
| Interaction | DYRK2 interactions | 6.99e-05 | 173 | 81 | 6 | int:DYRK2 | |
| Interaction | EPHA3 interactions | 8.50e-05 | 111 | 81 | 5 | int:EPHA3 | |
| Interaction | ERBB3 interactions | 9.00e-05 | 355 | 81 | 8 | int:ERBB3 | |
| Interaction | FRMD8P1 interactions | 9.52e-05 | 4 | 81 | 2 | int:FRMD8P1 | |
| Interaction | RPLP0P2 interactions | 9.52e-05 | 4 | 81 | 2 | int:RPLP0P2 | |
| Interaction | TOLLIP interactions | 9.54e-05 | 358 | 81 | 8 | int:TOLLIP | |
| Interaction | COPS5 interactions | ABCA1 CCNDBP1 UBAP2L MAX AHR RBM5 EWSR1 MDM2 WNK1 TFG HSPA1A HSPA1B HSPA6 HSPA8 | 1.16e-04 | 1102 | 81 | 14 | int:COPS5 |
| Interaction | HNF1B interactions | 1.17e-04 | 190 | 81 | 6 | int:HNF1B | |
| Interaction | DCUN1D1 interactions | 1.20e-04 | 275 | 81 | 7 | int:DCUN1D1 | |
| Interaction | AAK1 interactions | 1.28e-04 | 121 | 81 | 5 | int:AAK1 | |
| Interaction | NANOG interactions | 1.33e-04 | 481 | 81 | 9 | int:NANOG | |
| Interaction | TNRC6A interactions | 1.34e-04 | 280 | 81 | 7 | int:TNRC6A | |
| Interaction | TTC7A interactions | 1.35e-04 | 25 | 81 | 3 | int:TTC7A | |
| Interaction | BUB1B interactions | 1.35e-04 | 195 | 81 | 6 | int:BUB1B | |
| Interaction | CREBBP interactions | 1.41e-04 | 599 | 81 | 10 | int:CREBBP | |
| Interaction | ERCC8 interactions | 1.43e-04 | 124 | 81 | 5 | int:ERCC8 | |
| Interaction | AARSD1 interactions | 1.49e-04 | 125 | 81 | 5 | int:AARSD1 | |
| Interaction | BRCA2 interactions | 1.55e-04 | 384 | 81 | 8 | int:BRCA2 | |
| Interaction | BAD interactions | 1.55e-04 | 126 | 81 | 5 | int:BAD | |
| Interaction | MAGED1 interactions | 1.85e-04 | 295 | 81 | 7 | int:MAGED1 | |
| Interaction | MED15 interactions | 1.85e-04 | 131 | 81 | 5 | int:MED15 | |
| Interaction | CNOT3 interactions | 1.87e-04 | 207 | 81 | 6 | int:CNOT3 | |
| Interaction | EIF2AK1 interactions | 1.91e-04 | 28 | 81 | 3 | int:EIF2AK1 | |
| Interaction | SIRT6 interactions | 2.06e-04 | 628 | 81 | 10 | int:SIRT6 | |
| Interaction | CHTF8 interactions | 2.12e-04 | 29 | 81 | 3 | int:CHTF8 | |
| Interaction | NR4A1 interactions | 2.13e-04 | 212 | 81 | 6 | int:NR4A1 | |
| Interaction | BCOR interactions | 2.13e-04 | 302 | 81 | 7 | int:BCOR | |
| Interaction | COPS6 interactions | 2.33e-04 | 408 | 81 | 8 | int:COPS6 | |
| Interaction | TNRC6C interactions | 2.36e-04 | 138 | 81 | 5 | int:TNRC6C | |
| Interaction | KDM5C interactions | 2.44e-04 | 139 | 81 | 5 | int:KDM5C | |
| Interaction | HEY1 interactions | 2.53e-04 | 140 | 81 | 5 | int:HEY1 | |
| Interaction | EPS15 interactions | 2.59e-04 | 220 | 81 | 6 | int:EPS15 | |
| Interaction | WDR37 interactions | 2.76e-04 | 78 | 81 | 4 | int:WDR37 | |
| Interaction | RHOA interactions | ATP7A DSG2 STXBP5 TP63 ROBO1 QSER1 MDM2 TRRAP CLOCK HSPA1A HSPA6 HSPA8 PLXNA1 MAP3K1 | 2.77e-04 | 1199 | 81 | 14 | int:RHOA |
| Interaction | BAG4 interactions | 2.86e-04 | 224 | 81 | 6 | int:BAG4 | |
| Interaction | DNAJB4 interactions | 2.97e-04 | 145 | 81 | 5 | int:DNAJB4 | |
| Interaction | FBXO38 interactions | 2.97e-04 | 145 | 81 | 5 | int:FBXO38 | |
| Interaction | ILK interactions | 2.98e-04 | 319 | 81 | 7 | int:ILK | |
| Interaction | ANKRD17 interactions | 3.00e-04 | 226 | 81 | 6 | int:ANKRD17 | |
| Interaction | RNPS1 interactions | 3.07e-04 | 425 | 81 | 8 | int:RNPS1 | |
| Interaction | GLDC interactions | 3.09e-04 | 321 | 81 | 7 | int:GLDC | |
| Interaction | PNPLA5 interactions | 3.13e-04 | 33 | 81 | 3 | int:PNPLA5 | |
| Interaction | STAM2 interactions | 3.17e-04 | 147 | 81 | 5 | int:STAM2 | |
| Interaction | RNF43 interactions | 3.17e-04 | 427 | 81 | 8 | int:RNF43 | |
| Interaction | FOXJ2 interactions | 3.18e-04 | 81 | 81 | 4 | int:FOXJ2 | |
| Interaction | PIK3R2 interactions | 3.29e-04 | 230 | 81 | 6 | int:PIK3R2 | |
| Interaction | ESYT3 interactions | 3.31e-04 | 7 | 81 | 2 | int:ESYT3 | |
| Interaction | RNF207 interactions | 3.31e-04 | 7 | 81 | 2 | int:RNF207 | |
| Interaction | RYBP interactions | 3.45e-04 | 232 | 81 | 6 | int:RYBP | |
| Interaction | TET2 interactions | 3.47e-04 | 150 | 81 | 5 | int:TET2 | |
| Interaction | NACA interactions | 3.61e-04 | 234 | 81 | 6 | int:NACA | |
| Interaction | CDC20 interactions | 3.61e-04 | 234 | 81 | 6 | int:CDC20 | |
| Interaction | ANAPC2 interactions | 3.61e-04 | 234 | 81 | 6 | int:ANAPC2 | |
| Interaction | R3HDM1 interactions | 3.66e-04 | 84 | 81 | 4 | int:R3HDM1 | |
| Interaction | NES interactions | 3.69e-04 | 152 | 81 | 5 | int:NES | |
| Interaction | ATM interactions | 3.85e-04 | 333 | 81 | 7 | int:ATM | |
| Cytoband | 14q23 | 1.10e-04 | 9 | 81 | 2 | 14q23 | |
| GeneFamily | Heat shock 70kDa proteins | 1.91e-07 | 17 | 56 | 4 | 583 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 3.60e-05 | 21 | 56 | 3 | 89 | |
| GeneFamily | Fibronectin type III domain containing | 1.35e-04 | 160 | 56 | 5 | 555 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 3.36e-06 | 10 | 81 | 3 | MM1243 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | JAK3 ZBTB44 SETD2 RESF1 CCNDBP1 UBR5 DUSP6 ITSN2 DYRK1A AHR TNRC6C WNK1 JMJD1C HSPA8 LUZP1 PAPOLG | 1.12e-05 | 1492 | 81 | 16 | M40023 |
| Coexpression | AIZARANI_LIVER_C12_NK_NKT_CELLS_4 | 1.61e-05 | 49 | 81 | 4 | M39116 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 3.19e-05 | 289 | 81 | 7 | M2196 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 3.39e-05 | 197 | 81 | 6 | M5378 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | 3.69e-05 | 200 | 81 | 6 | M9765 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN | 3.69e-05 | 200 | 81 | 6 | M5679 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 5.87e-05 | 133 | 81 | 5 | M8880 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 6.75e-05 | 137 | 81 | 5 | MM990 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 7.02e-05 | 26 | 81 | 3 | M1380 | |
| Coexpression | MCCLUNG_COCAIN_REWARD_4WK | 8.26e-05 | 74 | 81 | 4 | M1600 | |
| Coexpression | MCCLUNG_COCAIN_REWARD_4WK | 9.17e-05 | 76 | 81 | 4 | MM682 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 1.11e-04 | 244 | 81 | 6 | M40312 | |
| Coexpression | NOJIMA_SFRP2_TARGETS_UP | 1.32e-04 | 32 | 81 | 3 | M14772 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.67e-04 | 166 | 81 | 5 | M6826 | |
| Coexpression | ONDER_CDH1_TARGETS_1_DN | 1.86e-04 | 170 | 81 | 5 | M6822 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | 1.88e-04 | 513 | 81 | 8 | M39069 | |
| Coexpression | SAFFORD_T_LYMPHOCYTE_ANERGY | 2.36e-04 | 97 | 81 | 4 | MM692 | |
| Coexpression | IGARASHI_ATF4_TARGETS_DN | 2.45e-04 | 98 | 81 | 4 | M4779 | |
| Coexpression | MIKKELSEN_DEDIFFERENTIATED_STATE_UP | 2.61e-04 | 8 | 81 | 2 | M1924 | |
| Coexpression | MIKKELSEN_DEDIFFERENTIATED_STATE_UP | 2.61e-04 | 8 | 81 | 2 | MM812 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.38e-04 | 300 | 81 | 6 | M8702 | |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 3.43e-04 | 194 | 81 | 5 | M3321 | |
| Coexpression | HELLER_SILENCED_BY_METHYLATION_DN | 3.43e-04 | 107 | 81 | 4 | M3185 | |
| Coexpression | PARK_HSC_MARKERS | 3.44e-04 | 44 | 81 | 3 | M6509 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP | 3.76e-04 | 198 | 81 | 5 | M5577 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP | 3.85e-04 | 199 | 81 | 5 | M8115 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP | 3.85e-04 | 199 | 81 | 5 | M7951 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 3.85e-04 | 199 | 81 | 5 | M9523 | |
| Coexpression | GSE3982_MAC_VS_TH1_UP | 3.85e-04 | 199 | 81 | 5 | M5510 | |
| Coexpression | GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP | 3.85e-04 | 199 | 81 | 5 | M5759 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 3.94e-04 | 200 | 81 | 5 | M6372 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN | 3.94e-04 | 200 | 81 | 5 | M6411 | |
| Coexpression | GSE14308_TH1_VS_TH17_DN | 3.94e-04 | 200 | 81 | 5 | M3374 | |
| Coexpression | GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP | 3.94e-04 | 200 | 81 | 5 | M7789 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 3.94e-04 | 200 | 81 | 5 | M302 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP | 3.94e-04 | 200 | 81 | 5 | M9942 | |
| Coexpression | GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN | 3.94e-04 | 200 | 81 | 5 | M9074 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 3.94e-04 | 200 | 81 | 5 | M7150 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP | 3.94e-04 | 200 | 81 | 5 | M5703 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | PTPN3 ATP7A RESF1 BRCA2 ADAMTS6 GLI3 CD34 DUSP6 LAMA1 MUC16 ROBO1 ROBO2 TSHZ1 ZDBF2 QSER1 HSPA1A HSPA8 | 6.71e-09 | 831 | 78 | 17 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | RESF1 DSG2 RADX GLI3 DUSP6 LAMA1 MUC16 ROBO1 ROBO2 TSHZ1 ZDBF2 | 5.45e-07 | 436 | 78 | 11 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | BRCA2 UBAP2L GLI3 DYRK1A EWSR1 QSER1 MDM2 WNK1 TFG LUZP1 EPHA5 | 1.81e-05 | 629 | 78 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.24e-05 | 418 | 78 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | 2.90e-05 | 432 | 78 | 9 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.68e-05 | 354 | 78 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SETD2 BRCA2 UBR5 STXBP5 GLI3 RBM5 ROBO2 NCKAP5 ZDBF2 LUZP1 EPHA5 PAPOLG | 4.81e-05 | 831 | 78 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | JAK3 ABCA1 EBF3 CD34 DUSP6 ITSN2 LAMA1 AHR ROBO1 ROBO2 NCKAP5 HSPA1B | 5.72e-05 | 846 | 78 | 12 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | ATP7A RESF1 DSG2 RADX GLI3 DUSP6 LAMA1 MUC16 ROBO1 ROBO2 TSHZ1 ZDBF2 | 5.92e-05 | 849 | 78 | 12 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 6.15e-05 | 58 | 78 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | PTPN3 RESF1 DSG2 RADX GLI3 DUSP6 LAMA1 MUC16 ROBO1 ROBO2 TSHZ1 ZDBF2 | 6.54e-05 | 858 | 78 | 12 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 9.21e-05 | 390 | 78 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 9.77e-05 | 125 | 78 | 5 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | ABCA1 DSG2 GLI3 TP63 AHR ROBO1 ROBO2 TSHZ1 TNRC6C EPHA5 PAPOLG | 1.11e-04 | 769 | 78 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.14e-04 | 207 | 78 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SETD2 BRCA2 ADAMTS6 STXBP5 ITSN2 RBM5 ROBO2 MDM2 HELQ LUZP1 PAPOLG | 1.26e-04 | 780 | 78 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.47e-04 | 311 | 78 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | PTPN3 EYA4 DSG2 TP63 DUSP6 ROBO1 NCKAP5 SIX4 HSPA1A HSPA1B EPHA5 | 1.58e-04 | 800 | 78 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_500 | 1.68e-04 | 75 | 78 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ATP7A GLI3 CD34 DUSP6 LAMA1 MUC16 ROBO1 ROBO2 TSHZ1 ZDBF2 HSPA8 | 2.10e-04 | 827 | 78 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.29e-04 | 150 | 78 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.73e-04 | 243 | 78 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_200 | 2.75e-04 | 156 | 78 | 5 | gudmap_developingGonad_e12.5_ovary_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#1_top-relative-expression-ranked_200 | 3.12e-04 | 36 | 78 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 4.93e-04 | 768 | 78 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | ABCA1 ATP7A LAMA1 MUC16 ROBO2 NCKAP5 ZDBF2 HSPA1A HSPA1B HSPA8 | 5.18e-04 | 773 | 78 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | EYA4 RESF1 BRCA2 ADAMTS6 EBF3 UBAP2L GLI3 ATF1 QSER1 SIX4 TFG MEAK7 PHC1 | 5.99e-04 | 1252 | 78 | 13 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 6.32e-04 | 793 | 78 | 10 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.76e-04 | 108 | 78 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_500 | 6.88e-04 | 47 | 78 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.10e-04 | 192 | 78 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.IEL, CD8a+ CD8b- TCRgd+ Vg5- CD44lo, Small Intestine, avg-3 | 7.19e-04 | 405 | 78 | 7 | GSM605811_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.27e-04 | 193 | 78 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_500 | 7.62e-04 | 409 | 78 | 7 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_500 | |
| ToppCell | COVID-19-kidney-T-cells-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.35e-06 | 191 | 81 | 6 | 698e6a28276704f8baa082d028db2345b973c4bc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.39e-06 | 192 | 81 | 6 | 3f925a80b5e2b0577d573e88598a2984a5f6a789 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-06 | 198 | 81 | 6 | 294a48ef6c0b89c7be948452cea79d23d3901e75 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.83e-06 | 145 | 81 | 5 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-05 | 169 | 81 | 5 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 179 | 81 | 5 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 81 | 5 | c2a8ee8679a1d71fcbff792cd516d3ce114f3ca6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.21e-05 | 185 | 81 | 5 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 2.21e-05 | 185 | 81 | 5 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.27e-05 | 186 | 81 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.27e-05 | 186 | 81 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 2.27e-05 | 186 | 81 | 5 | 6259f0f2d5bc863782d09a901d6be2f387d1f074 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.33e-05 | 187 | 81 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.33e-05 | 187 | 81 | 5 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-05 | 188 | 81 | 5 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | COVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 188 | 81 | 5 | 15484c05cb496cd98ed3f79a6134c5cec8f09a4d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 190 | 81 | 5 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | 390C-Myeloid-Mast_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-05 | 191 | 81 | 5 | 88bcd0b85b2112cef15c9e44d1429f9fba4a3400 | |
| ToppCell | 390C-Myeloid-Mast_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-05 | 191 | 81 | 5 | c1517ea7b10a7f732725b4c0224fbfecae80d18b | |
| ToppCell | 390C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-05 | 192 | 81 | 5 | 201d430af1e4fee7bc03baf0aca17db26f6f439a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 192 | 81 | 5 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | 390C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-05 | 192 | 81 | 5 | 15c1a0a0d07106118427135f166a1da710bf621a | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | 268925bfe85fb94a93a4ff8fe078d692df888140 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-05 | 194 | 81 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 2.78e-05 | 194 | 81 | 5 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-05 | 195 | 81 | 5 | 5a8b26f443684f9f194cc85a4a390144b7242403 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-05 | 196 | 81 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 2.92e-05 | 196 | 81 | 5 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | mLN-T_cell-Treg|T_cell / Region, Cell class and subclass | 2.99e-05 | 197 | 81 | 5 | 3779489d57ebda33277c79cba037f4c73128c8ba | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.99e-05 | 197 | 81 | 5 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.99e-05 | 197 | 81 | 5 | 6c42ce26574adcc6dfc5dd8109c9943fe5cf12d5 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 197 | 81 | 5 | cd54e6ad175529327fa0372033016b3b978dd452 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-05 | 197 | 81 | 5 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.99e-05 | 197 | 81 | 5 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 197 | 81 | 5 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.07e-05 | 198 | 81 | 5 | fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494 | |
| ToppCell | Basal-basal-7|World / Class top | 3.07e-05 | 198 | 81 | 5 | 240fe56b41b9435e62c66ac7161ef51f89e73e44 | |
| ToppCell | Caecum-T_cell-Th1|T_cell / Region, Cell class and subclass | 3.14e-05 | 199 | 81 | 5 | 13a80e6d3cf9c831edbe0644545071153e35f82b | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early|World / Primary Cells by Cluster | 3.14e-05 | 199 | 81 | 5 | 549391e7a4285da1c0e366654530bcf1cd33fbae | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.14e-05 | 199 | 81 | 5 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early-40|World / Primary Cells by Cluster | 3.14e-05 | 199 | 81 | 5 | 23625d757173bdd35a51c7919ff4b588168d2553 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 3.14e-05 | 199 | 81 | 5 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Sigmoid-T_cell-Th1|T_cell / Region, Cell class and subclass | 3.22e-05 | 200 | 81 | 5 | bc9433a8ec3a6f10816730a32b821c63d78e6e87 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-05 | 200 | 81 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.22e-05 | 200 | 81 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | VE-CD8-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 1.05e-04 | 134 | 81 | 4 | 4413fec495907184b6d5cf4bda39359506b2c172 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 51 | 81 | 3 | d43b0813f7c456f8fff77197fbbaef2f4d160563 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 148 | 81 | 4 | c240d506151fa90c59f40008c5fb31984c6f6f8f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 155 | 81 | 4 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.88e-04 | 156 | 81 | 4 | 7e6805ebc7bc2f9c5965321d16922c155719970f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.88e-04 | 156 | 81 | 4 | 741de05295b2d012ac8576378f37709a97c8fb50 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.02e-04 | 159 | 81 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-04 | 161 | 81 | 4 | d59713ca84aa2acadfc9b3150d5f525e1b288860 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-04 | 161 | 81 | 4 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Trm_Th1/Th17|bone_marrow / Manually curated celltypes from each tissue | 2.22e-04 | 163 | 81 | 4 | 4d1fd0b1246833723b938eca0cb246e937380e12 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.38e-04 | 166 | 81 | 4 | b041010038a570ad929812f35514cb54e4f68f66 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.38e-04 | 166 | 81 | 4 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 2.49e-04 | 168 | 81 | 4 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.61e-04 | 170 | 81 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Trm_gut_CD8|Lung / Manually curated celltypes from each tissue | 2.67e-04 | 171 | 81 | 4 | c8ccb7795ce8321739e3bc07db2ffc183d04e660 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.67e-04 | 171 | 81 | 4 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | Control-CD4+_T_activated|World / Disease group and Cell class | 2.79e-04 | 173 | 81 | 4 | 12f8e4276b290bb388a56de4c8d8dd60415b2f63 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.79e-04 | 173 | 81 | 4 | 5d3c917e4d0de3158550a8ab2006ddfa87159ffa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-04 | 174 | 81 | 4 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-5|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.85e-04 | 174 | 81 | 4 | 73e1ad4007d94fca25ed7c6fbe5d205d4e1b8a3b | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.85e-04 | 174 | 81 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.98e-04 | 176 | 81 | 4 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.04e-04 | 177 | 81 | 4 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.04e-04 | 177 | 81 | 4 | 15ee303fb6caea1fd645c3b777666196ce500a1c | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 3.04e-04 | 177 | 81 | 4 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 3.04e-04 | 177 | 81 | 4 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.04e-04 | 177 | 81 | 4 | 3d1b142aa2bd18df14816abaca356596b297394e | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 3.11e-04 | 178 | 81 | 4 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-04 | 179 | 81 | 4 | 9af894dfbe44e9706f5d178769ceda3b4e2d89c0 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.17e-04 | 179 | 81 | 4 | 02218c048e4dec0c0a3d63d2abb4feb4c3e82697 | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.24e-04 | 180 | 81 | 4 | 63e7ec20a93452a02bf904acebdbe3d0d9ae8894 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.24e-04 | 180 | 81 | 4 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-04 | 181 | 81 | 4 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.31e-04 | 181 | 81 | 4 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.31e-04 | 181 | 81 | 4 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | COVID-19-kidney-Mito-rich_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.31e-04 | 181 | 81 | 4 | 8448c2ad560cfd48bfe9dc1dd3a64373e6a622dd | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.45e-04 | 183 | 81 | 4 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.45e-04 | 183 | 81 | 4 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 183 | 81 | 4 | 983ca1342ddd365e1f1df32a456394b002b10e41 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 183 | 81 | 4 | f142b320023eef00b48d4820c46214c9794d37e7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 183 | 81 | 4 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | P15-Endothelial|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.45e-04 | 183 | 81 | 4 | ef82ce4658a775ee2ef0e564d2d1042898a1bd75 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-04 | 184 | 81 | 4 | 17ffa0e890960c00a3b5fa33d48caba66c61dbb0 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.51e-05 | 50 | 52 | 4 | GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.51e-05 | 50 | 52 | 4 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP | |
| Drug | Plant Oils | ABCA1 RESF1 DUSP6 AHR EWSR1 QSER1 HSPA1A TOX2 JMJD1C HSPA6 HSPA8 | 1.44e-06 | 496 | 81 | 11 | ctd:D010938 |
| Drug | Magnetite Nanoparticles | EYA4 ATP7A BRCA2 DSG2 UBAP2L STXBP5 GLI3 DUSP6 ITSN2 RBM5 QSER1 MDM2 HSPA1A TOX2 HSPA1B JMJD1C HSPA8 | 2.88e-06 | 1310 | 81 | 17 | ctd:D058185 |
| Drug | SC-58125; Up 200; 10uM; SKMEL5; HG-U133A | 7.06e-06 | 199 | 81 | 7 | 507_UP | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 1.98e-07 | 5 | 81 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Prostatic Neoplasms | SETD2 BRCA2 USP28 ITSN2 AHR ROBO1 ROBO2 EWSR1 MDM2 HSPA1A MAP3K1 | 9.70e-07 | 616 | 81 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | SETD2 BRCA2 USP28 ITSN2 AHR ROBO1 ROBO2 EWSR1 MDM2 HSPA1A MAP3K1 | 9.70e-07 | 616 | 81 | 11 | C0376358 |
| Disease | Malignant neoplasm of breast | SETD2 LRRC37A BRCA2 ITSN2 LRRC37A2 AHR ROBO1 SIX4 MDM2 WNK1 HELQ HSPA1B MAP3K1 DOP1A | 1.24e-06 | 1074 | 81 | 14 | C0006142 |
| Disease | Mammary Carcinoma, Human | 1.40e-05 | 525 | 81 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.40e-05 | 525 | 81 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 1.44e-05 | 527 | 81 | 9 | C1458155 | |
| Disease | Breast Carcinoma | 1.70e-05 | 538 | 81 | 9 | C0678222 | |
| Disease | Malignant Squamous Cell Neoplasm | 2.23e-05 | 3 | 81 | 2 | C0751688 | |
| Disease | Squamous Cell Neoplasms | 2.23e-05 | 3 | 81 | 2 | C0206720 | |
| Disease | Clear Cell Sarcoma of Soft Tissue | 4.45e-05 | 4 | 81 | 2 | C0206651 | |
| Disease | cortical thickness | EYA4 GLI3 LAMA1 ROBO1 ROBO2 NCKAP5 QSER1 CLOCK JMJD1C MYO16 MAP3K1 LUZP1 | 5.01e-05 | 1113 | 81 | 12 | EFO_0004840 |
| Disease | upper aerodigestive tract neoplasm | 6.08e-05 | 246 | 81 | 6 | EFO_0004284 | |
| Disease | Extraskeletal Myxoid Chondrosarcoma | 7.40e-05 | 5 | 81 | 2 | C1275278 | |
| Disease | cutaneous squamous cell carcinoma | 1.02e-04 | 33 | 81 | 3 | EFO_1001927 | |
| Disease | brain connectivity measurement | 1.17e-04 | 400 | 81 | 7 | EFO_0005210 | |
| Disease | Schizophrenia | CBLIF SLC26A8 ABCA1 CEACAM21 LAMA1 TRRAP CLOCK HSPA1A HSPA1B MYO16 | 1.51e-04 | 883 | 81 | 10 | C0036341 |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 1.55e-04 | 7 | 81 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 1.55e-04 | 7 | 81 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | Dental enamel hypoplasia, dental caries, tooth agenesis | 1.55e-04 | 7 | 81 | 2 | EFO_0003819, EFO_0005410, EFO_1001304 | |
| Disease | neuroimaging measurement | GLI3 TP63 ROBO1 ROBO2 NCKAP5 QSER1 MEAK7 JMJD1C MYO16 MAP3K1 LUZP1 | 1.60e-04 | 1069 | 81 | 11 | EFO_0004346 |
| Disease | eosinophil percentage of leukocytes | 2.07e-04 | 746 | 81 | 9 | EFO_0007991 | |
| Disease | mean corpuscular hemoglobin concentration | SLC26A8 UBR5 UBAP2L PCDHGA5 MAX LRRC37A2 MDM2 TOX2 MEAK7 HSPA8 MYO16 | 2.13e-04 | 1105 | 81 | 11 | EFO_0004528 |
| Disease | Major depression, single episode | 2.65e-04 | 9 | 81 | 2 | C0024517 | |
| Disease | reaction time measurement | 4.51e-04 | 658 | 81 | 8 | EFO_0008393 | |
| Disease | Alzheimer's disease (is_implicated_in) | 4.88e-04 | 132 | 81 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | waist-hip ratio | ABCA1 EYA4 ADAMTS6 GLI3 CD34 DUSP6 ROBO1 WNK1 CLOCK JMJD1C PHC1 | 5.13e-04 | 1226 | 81 | 11 | EFO_0004343 |
| Disease | Atherosclerosis | 5.80e-04 | 59 | 81 | 3 | C0004153 | |
| Disease | Atherogenesis | 5.80e-04 | 59 | 81 | 3 | C1563937 | |
| Disease | melanoma | 6.14e-04 | 248 | 81 | 5 | C0025202 | |
| Disease | response to opioid | 6.39e-04 | 61 | 81 | 3 | EFO_0008541 | |
| Disease | Colorectal Carcinoma | 6.89e-04 | 702 | 81 | 8 | C0009402 | |
| Disease | Down syndrome (implicated_via_orthology) | 7.64e-04 | 15 | 81 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | squamous cell carcinoma | 8.41e-04 | 67 | 81 | 3 | EFO_0000707 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 9.34e-04 | 157 | 81 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | non-small cell lung carcinoma | 1.17e-03 | 75 | 81 | 3 | EFO_0003060 | |
| Disease | Inguinal hernia | 1.18e-03 | 287 | 81 | 5 | HP_0000023 | |
| Disease | alpha-tocopherol measurement | 1.37e-03 | 20 | 81 | 2 | EFO_0007898 | |
| Disease | Carcinoma of lung | 1.81e-03 | 23 | 81 | 2 | C0684249 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.98e-03 | 24 | 81 | 2 | C0887833 | |
| Disease | complement C4b measurement | 2.14e-03 | 25 | 81 | 2 | EFO_0008092 | |
| Disease | DNA methylation | 2.18e-03 | 656 | 81 | 7 | GO_0006306 | |
| Disease | Cholangiocarcinoma | 2.32e-03 | 26 | 81 | 2 | C0206698 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 2.32e-03 | 26 | 81 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 2.32e-03 | 26 | 81 | 2 | EFO_0007870 | |
| Disease | Adenocarcinoma of large intestine | 2.37e-03 | 96 | 81 | 3 | C1319315 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.52e-03 | 206 | 81 | 4 | C0152013 | |
| Disease | Alzheimer disease, age at onset | 2.57e-03 | 343 | 81 | 5 | EFO_0004847, MONDO_0004975 | |
| Disease | Pancreatic Neoplasm | 2.66e-03 | 100 | 81 | 3 | C0030297 | |
| Disease | blood cobalt measurement | 2.74e-03 | 101 | 81 | 3 | EFO_0007577 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YPAELNNINNTQTTT | 811 | P35869 | |
| QPTDVSYTQAQTTAT | 46 | Q01844 | |
| NYQSSVQGSSQSQST | 466 | Q9BWU1 | |
| QSQSTLGYSSSSQQS | 476 | Q9BWU1 | |
| YESVAQPSIQASSTT | 141 | Q3KPI0 | |
| QYVSVNVTTNQAAPS | 456 | P54756 | |
| VNSSSSSTQIYQAVS | 291 | O95477 | |
| NPQSATETASSEQYL | 106 | Q5T686 | |
| NAISTTSVNNAYTPQ | 1401 | Q5JWR5 | |
| RVYNSPTNSSSTQDS | 631 | Q13627 | |
| LNDTSTVSYSLPINN | 221 | Q9UKP5 | |
| SQQRSPSYTNDSTAT | 266 | Q04656 | |
| SSQTVTPENQTLNYS | 381 | Q2KHR3 | |
| SQGLSPVSQTQVSYS | 431 | Q2KHR3 | |
| PVSQTQVSYSSQSQV | 436 | Q2KHR3 | |
| NQPASVTDYQNVSFS | 851 | Q9NZM3 | |
| TSSLVQPQSQYQLSQ | 496 | P52333 | |
| NFPQASYSTSVTENN | 451 | Q9Y5G8 | |
| SENNPAQSYLTQKSS | 441 | P26045 | |
| PVNSQYFQTTSTNLS | 606 | Q6NSI4 | |
| TLQSSYQIPTENSMT | 1056 | Q14126 | |
| SVQTQSTPYVNSVAV | 1996 | Q8WXI7 | |
| STPQSQKQTLQNEYS | 171 | O60309 | |
| QKQTLQNEYSSTDTP | 176 | O60309 | |
| SSCSSQQSPISNYSN | 711 | P10071 | |
| EKSQSPQTSQVSSYL | 841 | Q9P2G4 | |
| RSSAQLQTNYPSSDN | 106 | P61244 | |
| STPQSQKQTLQNEYS | 171 | A6NM11 | |
| QKQTLQNEYSSTDTP | 176 | A6NM11 | |
| STPQSQKQTLQNEYS | 171 | A6NMS7 | |
| QKQTLQNEYSSTDTP | 176 | A6NMS7 | |
| YPESNTNLTETMNTT | 271 | Q8NI17 | |
| QSLLESSNTNAVYSP | 871 | Q9Y6X6 | |
| QSLPQSNYFTTLSNS | 1086 | Q15652 | |
| SYDSNSLTVSLNNPS | 3906 | Q5CZC0 | |
| PTKQTQIFTTYSDNQ | 421 | P0DMV9 | |
| VPKQTSAYNISNSST | 1601 | Q9UIW2 | |
| TYPQQNRSLSSQSYS | 796 | Q8TE49 | |
| SQQQTTQYIITTTTN | 1121 | Q9NQV6 | |
| TCTTYNSPQLSAQEN | 386 | Q6P9B6 | |
| AAVVSQSPQLYNQTS | 406 | P52756 | |
| QQNSTYNVSTSTRTV | 321 | Q9BWT3 | |
| DQQIQNGSSSTSPYN | 121 | Q9H3D4 | |
| APSSTIYANNSVSNS | 246 | O95677 | |
| PTSASNITVIYTINN | 306 | P27352 | |
| TNQSPYSVIENSALA | 1656 | P51587 | |
| TQSPENNDLISYNSV | 141 | O95273 | |
| NTSISSVQLPTNVYN | 201 | Q7Z3S7 | |
| NENYSLSNRQVSSPS | 411 | Q86V48 | |
| SQVEGYLSSQPTQNT | 471 | Q6PJP8 | |
| QTQTFTTYSDNQPGV | 426 | P17066 | |
| PTKQTQIFTTYSDNQ | 421 | P0DMV8 | |
| PSSQAIYFENLQNSS | 196 | Q8TDG4 | |
| STPQQSNYNTVSTSM | 476 | Q9H4W6 | |
| TPSNQNVYQVDSLQS | 366 | Q16828 | |
| NVSTNVSYQETTTPS | 51 | P28906 | |
| SVYGNTNSSVQSQTS | 101 | P28906 | |
| PTKQTQTFTTYSDNQ | 421 | P11142 | |
| QASVPNNYLETTENS | 886 | Q13233 | |
| IPSQNQTSLTYSQGS | 5126 | O75445 | |
| EPQTSTSQNVSFSAQ | 161 | Q9HCJ0 | |
| TESFSSRTVTQNPQQ | 756 | O14513 | |
| TSAVPSQQYATQTDK | 261 | Q9HCM1 | |
| NTSQTASEDQVPYTV | 651 | Q96RN1 | |
| QPQISSTNYNTLTLN | 2131 | P25391 | |
| SQSQESEDYSQPSTS | 386 | Q00987 | |
| STVTSVSNTNYATLQ | 651 | Q9UIU6 | |
| VSPSSSQEISENQYA | 901 | Q5T5C0 | |
| QTTDSLPLTTYTSQV | 406 | Q9NZP6 | |
| STQQGTTILQYAQTS | 141 | P18846 | |
| TAYPTFATQQQQSQT | 736 | O15516 | |
| QTVQPSISQTCTSYG | 21 | Q5K130 | |
| IQSTTYTSQNNAQGP | 576 | Q14157 | |
| AQTYTAQTSQPTNYT | 326 | Q92734 | |
| QTSSPQVLNSSASYS | 201 | Q8NCP5 | |
| SPQSTSDYPQQSVTE | 501 | Q9HCK1 | |
| NSSVTAQPAQTSYLS | 436 | O75886 | |
| SNLQSATGTTAYTQQ | 466 | O75886 | |
| DMSSYQNTTSNLPQL | 486 | O75886 | |
| PSQTLISSATYTQIQ | 361 | P78364 | |
| NSSSQITQATPYATT | 986 | Q9HCK4 | |
| TPYATTQLIQSNLSN | 1071 | Q9Y6N7 | |
| NSSSQDYSTSQEPSV | 711 | Q96RU2 | |
| SVQQQYSPAQSQATI | 2281 | Q9BYW2 | |
| PEYINSAVSSQTLSQ | 86 | Q8N9P0 | |
| NPELLSTSQTYNGQS | 56 | Q96NM4 | |
| PQQTVQYSLSQTSTS | 751 | Q9H4A3 | |
| SENFENVTSSPQYST | 46 | Q9Y4A5 | |
| AQSYQNSPVSSATNQ | 56 | Q6ZSZ6 | |
| SYSVSSNSLPINVQV | 286 | Q12836 | |
| SSQSQSSYIIRNPQQ | 1531 | O95071 |